Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1 participants
INTERVENTIONAL
2015-08-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Trial Into the Efficacy of rTMS Treatment for Treating Anorexia Nervosa and Bulimia Nervosa
NCT04061304
Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa
NCT05368844
Identifying Networks Underlying Compulsivity in Anorexia Nervosa for Targeting With Neuromodulation
NCT06138782
Reward Systems and Food Avoidance in Eating Disorders
NCT02795455
Mechanisms of Deep Transcranial Magnetic Stimulation in Enhancing Cognitive-Behavioral Therapy for Anorexia Nervosa
NCT06942858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TMS Treatment Group
15 sessions active Transcranial magnetic stimulation (TMS) treatment
Transcranial magnetic stimulation
TMS
TMS Sham Group
15 sessions sham Transcranial magnetic stimulation (TMS) treatment
Transcranial magnetic stimulation
TMS
tDCS Treatment Group
15 sessions active Transcranial direct current stimulation (tDCS) treatment
Transcranial direct current stimulation
tDCS
tDCS Sham Group
15 sessions sham Transcranial direct current stimulation (tDCS) treatment
Transcranial direct current stimulation
tDCS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial magnetic stimulation
TMS
Transcranial direct current stimulation
tDCS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets DSM-5 criteria for anorexia nervosa (AN) either binge-eating/purging type or restricting-type:
* Intense fear of gaining weight or becoming fat, even though underweight.
* The ability to undergo an MRI, fMRI or other similar procedure requiring spending time in an enclosed space
* Bulimia Nervosa subjects:
* Meet DSM-5 criteria for bulimia nervosa (BN):
* Self-induced vomiting; misuse of laxatives, diuretics, enemas, medication, fasting, excessive exercise.
Exclusion Criteria
* No symptoms of alcohol or other substance abuse or dependence in the past 3 months,
* No previous or current organic brain syndromes, dementia, psychotic disorders, somatization disorders, or conversion disorder, head trauma, indication of mental retardation or pervasive developmental disorder.
* No antipsychotics, tricyclic antidepressants or Wellbutrin or other medication that may lower the seizure threshold.
* Claustrophobia.
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guido K. Frank, MD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Denver and Health Science Center
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-2716
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.